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Abstract 
 
Tissue Engineering is a multidisciplinary field of study based on the techniques, methods 
and knowledge of biology, medicine and engineering. The aim is to produce artificial devices 
able to act as temporary substitutes of damaged tissues: the structure realized must serve as 
supports for cell attachment and proliferation as well as the production of extracellular 
matrix, ideally until the same device degrades. The great issues related to this approach are 
therefore implementing a suitable scaffold material produced with an adequate technique in 
order to satisfy the above requirements. 
In this Thesis project, an alkali-free bioactive glass composition in the binary system of 
Diopside-Tricalcium Phosphate that has already shown promising properties for tissue 
engineering and bone regeneration was selected. The robocasting technique was adopted for 
manufacturing 3D porous scaffolds with adequate structures and porosities designed by 
CAD.  
The work included different steps such as: (i) preparation and characterization of glass 
powders with different particle size distributions to enhance the packing ability; (ii) 
preparation of concentrated suspensions and investigate the dependence of their rheological 
properties on solid loading and the content of CMC selected as the single processing 
additive; (iii) production of the scaffold with different porosity; (iv) characterization of the 
printed structures before and after sintering process. 
The results obtained demonstrated that a 1:1 mixture of glass powders having mean particle 
diameters of 1 µm and 45 µm enables preparing suitable suspensions by playing with the 
contents of CMC and solid loading. The printed scaffolds present well-defined geometry and 
good shape retention. The work carried out could be considered as a very promising starting 
point for further studies aiming at obtaining further improvements.  
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 CHAPTER 1 
 
Introduction 
 
 
In this chapter, a brief general introduction to the main aspects of this Thesis is made, including 
the motivations behind the proposal, stating the overall objectives we intend to achieve, and 
experimental approach we want to test. The general organization of this Thesis will be also 
exposed.  
 
1. Framework 
The life expectancy has been increased in the last centuries, mainly cause of the improvement 
of medicine and researches around medical innovations. On the other hand, the rise of life span 
has led to deal with the population ageing and, consequently, the diseases associated to it, such 
as osteoarthritis and osteoporosis (1). These conditions of the musculoskeletal system imply the 
loss of continuity and strength of the bone section and are mainly caused by the lack of 
nutritional, pathologic or metabolic factors, mostly associated with the increasing of sedentary 
life. This deficiency leads to an imbalance between the cells which work on the bone tissue: 
osteoblasts that contribute to the tissue formation, and osteoclasts, which permit bone 
reabsorption. When the activity of osteoclasts prevails over that of osteoblasts the bone starts 
to degrade (2). 
To overcome those bone diseases many improvements were made along the last decades aiming 
at developing new bone regeneration strategies and especially by combining bioengineering 
technologies and methods with medicine in the field of tissue repair (3). 
This solution presented is associated with the tissue engineering, an interdisciplinary field that 
applies the knowledge of engineering, biology and chemistry in solving the critical medical 
problems of tissue loss and organ failure. The great issue related to this work is the 
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manufacturing of a device suitable to bone tissue repair, thus enabling regeneration, especially 
from the functionality recovery perspective. 
From this point of view, it must be ensured not only a certain internal structure (interconnected 
porosity) but also specific chemical properties that enable scaffold material to promote tissue 
regeneration (4). As such, the material should meet a set of important requirements: must be 
biocompatible and bioactive to facilitate cells colonization and have an adequate interaction 
with human body, to avoid the attack of the immunity system, but also shows adequate 
mechanical properties to support the load during recovery. Nowadays many materials can be 
used for scaffold, either naturals or synthetics: in the field of bone tissue repair, bioactive 
glasses show promising characteristics, thanks to the high interfacial bonding and response as 
they interact with body fluids (5).   
Choosing the material is not the only main issue; the processing technique is also important 
since it will directly affect the final properties, mechanical and especially structural, of the 
scaffold. From this perspective, there are numerous processing techniques to produce bioactive 
glass scaffolds. Best results have been obtained with Solid Freeform Fabrication (SFF) instead 
of conventional production methods, because it allows a high control of the printed structure. 
However, this kind of technique is based on the creation of a stable suspension: the analysis 
and control of its rheological properties is fundamental in order to be able to extrude the paste 
and to obtain at the end, a scaffold with precise geometry. 
  
2. Objectives 
The aim of this Thesis is to produce scaffold for bone tissue regeneration by using an alkali-
free bioactive glass with robocasting technology: the association of both these requests 
represent a novelty in this field of research. In fact, the most well-known is the alkali-containing 
45S5 Bioglass®, which has been implemented many times in tissue engineering but presents 
several problems that derive mostly from its high sodium content (6). The leaching of sodium 
and the consequent ionic exchange with hydrogen ions results in suspensions with high pH 
values, making the processing in aqueous environment very difficult (7).  
To overcome these problems, an alkali-free bioactive glass composition was selected consisting 
of 70 Diopside (Di) and 30 Tricalcium Phosphate (TCP) (wt.%), corresponding to (mol%):  
36.52 𝐶𝑎𝑂 – 19.24 𝑀𝑔𝑂 – 38.48 𝑆𝑖𝑂2– 5.76 𝑃2𝑂5 (8). The easiness of processing is expected 
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to enable the fabrication of porous 3D structures with well-defined pore sizes (both micro and 
macro) and interconnectivities. The absence of alkaline oxides is expected to enhance the 
easiness of colloidal processing in aqueous media and obtain suspension with high solid 
loadings and rheological properties suitable for additive manufacturing by the robocasting 
process. 
This study should be considered as a preliminary research about if the merge of these two 
technologies (the alkali-free bioactive glass and the robocasting). Both of them have already 
been studied and implemented in different systems: their union should be, not only promising 
from the theoretical point of view, but also from the practical one.  
 
3. Thesis Organization 
This Thesis work will be divided in different parts. This first Chapter provides a general 
introduction to the topic, states the motivations behind it, announces the main intended 
objectives, highlights the novelty aspects, and gives account about the experimental approach 
that will be followed along the study. Chapter 2 reviews the state of the art in this area and 
highlights the aspects that still need to be improved, thus justifying the undertaking of this work. 
Chapter 3 will describe all the aspects related to experimental procedures adopted along the 
Thesis. Chapter 4 will present the results obtained and the related discussion. The main 
conclusions will be presented in Chapter 5, while any future issues worthy to be further 
investigated in the future will be pointed out in in Chapter 6.  
 
  
 
 
 
 CHAPTER 2 
 
State of Art 
 
 
This Chapter presents an updated overview about the state of art on this field of research, 
including the main issues related to bone tissue injury and regeneration, as well as how 
bioglass composition affects its degradation, bioactivity, thermal properties and processing 
ability. 
 
1. Bone tissue, injury and regeneration 
1.1. Structure of bone tissue 
Human skeletal system is the internal skeleton that serves as a framework for the body. This 
framework consists of many individual bones, cartilages and bands of fibrous connective 
tissue—the ligaments and the tendons—in intimate relationship with the parts of the 
skeleton (9). 
The functions of the skeleton are of three different types: support, protection, and motion. 
The great majority of the skeletal muscles are firmly anchored to the skeleton, usually to at 
least two bones and in some cases to many bones. Thus, the motions of the body and its 
parts, all the way from the lunge of the football player to the delicate manipulations of a 
handicraft artist or of the use of complicated instruments by a scientist, are made possible 
by separate and individual engineering arrangements between muscle and bone (10). 
Bones are divided into four basic types based on the shape of the bone: they can be long, 
short, flat or irregular. Long bones are longer than they are wide and are primarily found in 
the appendages (arms and legs). They include the femur, tibia, fibula, radius, ulna, and 
humerus. Long bones are slightly curved for strength and designed to absorb stress at several 
points. Short bones are basically cube shaped and are about as wide as they are long. 
Examples are the bones found in the wrist and ankle. Flat bones are thin and generally flat. 
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They offer considerable protection and a great deal of surface area for muscles to attach. 
Examples of flat bones are the cranial bones, which protect the brain, and the scapula 
(shoulder blade). Irregular bones include many of the bones that do not fall into the other 
three categories. They have complex shapes and include bones like the vertebrae (11). 
Bone tissue can be described as a hard and consistent organ which composes the skeleton of 
vertebrates and considered as a mineralized connective tissue formed by cells, that deposit a 
matrix of collagen and release Ca, Mg and 𝑃𝑂4
3− ions which combine with the matrix to 
form a “bone mineral” (hard and flexible). There are two type of bone tissue: cortical, 
composes the compact and hard zone of the bone (external), and cancellous, the spongy 
internal structure of the bone. 
 
Their structures imply that the two types differ in density, or how tightly the tissue is packed 
together. The lighter type (cancellous) is in the internal zone of the bone, while the compact 
one (cortical) composes the external part, as it’s showed in Figure 1.  The spongy bone is 
less dense and contains spaces so blood vessels and other nutrients can be supplied to the 
bone. The compact part of the bone contains few spaces and provides protection and 
strength. The differences of structure and functions between these parts of the bone lead also 
to different mechanical behaviour: it’s been researched that the density of the bone directly 
affect its stiffness and its response to external loadings and forces. From this point of view, 
even if both made of the same material, the spongy part tends to present a Young’s Modulus 
Figure 1. Internal structure of the bone. (68) 
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value ten times less than the compact one, since it’s around 1GPa, while the other is about 
17GPa (12) (13) (14) (15). 
Bone contains a relatively small number of cells entrenched in a matrix of collagen fibers 
that provide a surface for inorganic salt crystals to adhere. These salt crystals form when 
calcium phosphate and calcium carbonate combine to create hydroxyapatite, which 
incorporates other inorganic salts like magnesium hydroxide, fluoride, and sulphate as it 
crystallizes, or calcifies, on the collagen fibers. The hydroxyapatite crystals give bones their 
hardness and strength, while the collagen fibers give them flexibility so that they are not 
brittle. Although bone cells compose a small amount of the bone volume, they are crucial to 
the function of bones. There are different types of cells that contribute to bone homeostasis: 
osteoblasts, osteoclasts and osteocytes (16). The most important are osteoblasts, which are 
bone-forming cell, and osteoclasts which can resorb or break down bone. The equilibrium 
between these cells maintains the bone tissue in its healthy form. (17) 
 
1.2. Bone tissue growth 
The skeleton of the human body starts to form in the fourth month of pregnancy, together 
with cartilage and connective tissue. This process is known as ossification, and it specifically 
indicates the natural process of bone formation, which could be simplified to the process of 
proliferation of mesenchymal cells which later condense into compact nodules. Some of 
these cells develop into osteoblasts, which secrete a collagen-proteoglycan matrix that is 
able to bind calcium salts. Through this binding, the prebone (osteoid) matrix becomes 
calcified. (18) In most cases, osteoblasts are separated from the region of calcification by a 
layer of the osteoid matrix they secrete. Occasionally, osteoblasts become trapped in the 
calcified matrix and become osteocytes—bone cells. The entire region of calcified spicules 
becomes surrounded by compact mesenchymal cells that form the periosteum (a membrane 
that surrounds the bone). The cells on the inner surface of the periosteum also become 
osteoblasts and deposit osteoid matrix parallel to that of the existing spicules. In this manner, 
many layers of bone are formed. 
Bone development continues also throughout adulthood enduring the repair of fractures and 
the remodelling the bone structure (19): it can be simplified to a matrix resorption from one 
to another bone surface (injuries, exercise and other activities lead to this process) (9). 
Chapter 2 
 
8 
 
 
1.3. Bone tissue injury and regeneration 
The injury of bone tissue can be caused by different events like trauma, cancer and aging. 
Generally, all these events lead to the loss of continuity of the bone structure or its 
inflammation and degradation.  
 
The bone remodelling process is under the control of local (i.e., growth factors and 
cytokines) and systemic (i.e., calcitonin and oestrogens) factors that all together contribute 
to bone homeostasis. Bone metabolism relies on complex signalling pathways and control 
mechanisms to achieve proper rates of growth and differentiation. These controls include the 
action of several hormones.  
The remodelling cycle of bone tissue consists of three consecutive phases, as shown in 
Figure 2: resorption, during which osteoclasts digest old bone; reversal, when mononuclear 
cells appear on the bone surface; and formation, when osteoblasts lay down new bone until 
the resorbed bone is completely replaced. An imbalance between bone resorption and 
formation can result in bone diseases including osteoporosis.  
The regeneration of bone tissue is possible and is conducted by the process of tissue 
calcification, but this procedure is not always permitted (due to the site of the fracture, i.e. 
dental bone, where tissue regeneration cannot take place naturally, but may need the 
implantation of some devices or stem cells (20)) or the best solution (because i.e. it can lead 
to the stiffening of bones that are usually flexible). 
 
2. Current clinical approaches for bone repair 
Current clinical procedures that involve the repair of bone defects include implantation or 
transplantation. 
Figure 2. Processing of remodelling of an injured bone. (54) 
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2.1. Implantation 
It’s possible to classify an implant as any external artificial device which will be inserted in 
the human body in order to recover a failed tissue or biological structure. Implants can be 
made out from different materials, both bioinert, such as titanium or silicone, which are 
chemically stable but tend to have minimal interactions with the human body, both 
biodegradable and bioabsorbable, such as lactic acid copolymers and bioglasses (21).  
It’s necessary to underline, however, how these last types of materials were implemented 
only in recent times (some specific application is reported from literature (22) (23)), while, 
bioinert materials were the first type of implants used as tissue recovers. 
The problems of this first approach involving bioinert artificial implants are their lack of 
self-repair, blood supply and structural adaptation to external factors, such as mechanical 
load. The contact between body internal apparatus, the immune system and the inert 
synthetic material might also bring some complications (24).  
Is it known that no material is completely inert when in the biological environment. When 
inertness prevails, the material lives as a host trying to support the injured tissue but also 
interact with the external environment and suffers from the immune attack. This leads to the 
negative response of the body organism, which also depends on the composition, 
morphologic and geometric characteristics of the surface. 
Many attempts have been made (25) to create artificial implants with an appropriate outside 
layer or different composition (26) but this solution only evaluates the mechanical properties 
(27) and osteointegration (28). 
Lack of self-repair, blood supply and adaptation to external factors are other characteristics 
of the artificial implantation method. The issue with those is that, even if it is inert, the 
material installed is not everlasting and needs to be replaced after 10-15 years, due to the 
wear and stresses it undergoes during its life (29).   
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2.2. Transplantation 
Transplantation is defined in surgery as the act to transfer an organ (i.e. hearth, kidneys, 
liver) or a tissue (i.e. bones, tendons, cornea) from one part of the body, of one person, to 
another. Here there is no problem about the inert behaviour of the bone repair device, 
because it is a natural material which will interact with the body environment and structures 
as it already did.  
This type of method is not lack of shortcomings, which include the long waiting list, the little 
number of compatible donors and the risk of rejection or infection.  
In both cases, artificial or prosthetic materials for replacing limbs, teeth, and other tissues 
resulted in the partial restoration of lost function and not its complete recovery of their 
natural activity. 
 
3. Bioengineering strategy 
Bioengineering can be described as an interdisciplinary application of two main sciences, 
engineering and medicine: the aim of this merge is to fill the gap between methods, 
technologies of mechanics, and the understanding of the human body.   
Tissue engineering is a segment of this study that applies the knowledge of bioengineering 
in solving the critical medical problems of tissue loss and organ failure. Tissue engineering 
has been formally defined as “the application of the principles and methods of engineering 
and the life sciences to the fundamental understanding of structure–function relationships in 
normal and pathological mammalian tissues and the development of biological substitutes 
that restore, maintain, or improve tissue function”. The idea is to produce a scaffold, made 
by different kind of materials, suitable for tissue cells colonization and its subsequent 
growth. This is possible by the harvesting of stem cells from the patient, which are then 
cultured on the scaffold that can be implanted after (30). What tissue engineering is trying 
to accomplish is to replace synthetic implants and tissue grafts, already being used in 
medicine, with the bioengineering approach that uses porous material scaffolds integrated 
with biological cells or molecules to regenerate tissues. Therefore, this new paradigm 
requires scaffolds that balance temporary mechanical function with mass transport to aid 
biological delivery and tissue regeneration in three dimensions. The synthetic scaffold, being 
used, should be as short lived as possible; at the same time, the scaffold must maintain its 
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viability and integrity long enough for the cells to produce their own extracellular matrix 
(30) (31).  
Tissue engineering can now rely on numerous research projects and papers which attest the 
benefits this science field can bring to tissues repair.  
Primarily, it is based on nature imitation: this overcomes the main problem of 
transplantation, which is the shortage of donor tissue and organs and their compatibility with 
the patient body (32). Moreover, materials used to produce scaffolds are often biodegradable 
or bioabsorbable and this leads to the non-inert behaviour of the created structure and its 
complete interaction with human body environment. Designed material should not act just 
as a static replacement of the injured tissue but must can cause a cellular response: the 
scaffold implanted will degrade under immune system attack, with a certain rate, to allow 
colonization and cells growth, and to leave behind the renewed tissue (33).  
 
3.1. Bioactive Glasses 
As mentioned in previous sections, scaffolds can be made out from different biodegradable 
or bioabsorbable materials: their composition and internal structure will affect their 
behaviour when in contact with biological environment. The idea is to create a solid capable 
of connecting to living tissues, and so able to allow cells colonization, but also capable to 
degrade. Generally, this type of materials has been formally defined as biomaterials.  
A biomaterial is now defined as a substance that has been engineered to take a form which, 
alone or as part of a complex system, is used to direct, by control of interactions with 
components of living systems, the course of any therapeutic or diagnostic procedure. It can 
formally be defined as any matter, surface, or construct that interacts with living systems. 
Therefore, an ideal synthetic bone graft is a porous material that can act as a temporary 
template for bone growth in three dimensions. It should: 
1. be biocompatible and bioactive, promoting osteogenic cell attachment and 
osteogenesis; 
2. bond to the host bone without fibrous tissue sealing it off from the body; 
3. have an interconnected porous structure that can allow fluid flow, cell migration, 
bone ingrowth and vascularization; 
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4. be able to be cut to shape in theatre so that it can fit the defect (for some applications, 
clinicians may prefer porous granules to a single block); 
5. degrade at a specified rate and eventually be remodelled by osteoclast action; 
6. share mechanical load with the host bone and maintain an appropriate level of 
mechanical properties during degradation and remodelling; 
7. be made by a fabrication process that can be up-scalable for mass production; 
8. be sterilisable and meet regulatory requirements for clinical use. 
From this perspective, the above list can be summarized in the research of a material that 
could mimic the porous cancellous part of the bone tissue (12). 
Today, materials used for scaffolds are natural or synthetic polymers such as 
polysaccharides, poly (a-hydroxyester), hydrogels or thermoplastic elastomers. Other 
important categories of materials are bioactive ceramics such as calcium phosphates and 
bioactive glasses or glass-ceramics. Specifically, those types of materials have a high 
interfacial bonding and response when in contact with internal body tissue.  
 
Table 1. Representation of the main advantages and disadvantages of the principal classes of biomaterials. 
Biomaterial Advantages Disadvantages 
Polymer 
Composition flexibility, film and 
gel form 
Weak, low mechanical 
properties 
Metal 
High strength, ductility, wear 
resistance 
Low biocompatibility, 
corrosion, metal ions 
release 
Composite 
High elastic strength, low modulus, 
absence of corrosion 
Short-term durability 
Ceramic/Glass 
Biocompatible, compression and 
corrosion resistance 
Brittle, low fracture 
strength, high density 
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As mentioned, the idea of bioengineering is to create a scaffold, or surface, able to imitate 
the functions and resistance properties of the tissue to recover. The choice of the material is 
a fundamental: this should both ensure mechanical assistance and to provide a suitable 
surface for cells to adhere, colonize and differentiate in order to promote the tissue 
regeneration. The biocompatibility, by this perspective, is one of the most attractive glass 
ceramics’ properties, even if, as mentioned in the scheme (Table 1) above, those materials 
are characterised by brittle structure and high density. In fact, glass ceramics in general 
present adequate strength and interaction with living matter; especially, they tend to form a 
layer of hydroxyapatite (HA) on their surface: this mineral makes bioglass an active material. 
This means that it is osteoconductive, so able to serve as a scaffold for viable bone healing 
and permit infiltration of osteogenic precursor cells, and able to promote osteogenesis, which 
is the ability of the graft to produce new bone. bioglass is also osteoinductive: it is equipped 
to induce stem cells to differentiate into mature bone cells (34). This process is typically 
associated with the presence of bone growth factors within the graft material.  
The main issue is now the production of a scaffold with a certain structure and made by 
bioactive glass. Only the correct combination of these factors can output a product able to 
permit bone tissue regeneration; correct pores size, vascularization, cells diffusion, and 
mechanical properties strictly depend on glass composition and how the scaffold is 
manufactured. Another important feature of biomaterials in general, is their ability to 
degrade under the attack of the immune system. This means that the material will dissolve 
in fragments and permit also the leaching of the ions which compose the scaffold: from this 
perspective, a lot of researches around biomaterials concerned how the elements of the 
choose material could affect both tissue regeneration and body response to the external 
device.  
 
3.2. Bioactive glasses: previous researches and novelties 
The first bioactive glass was developed in 1970 by Larry Hench and colleagues. This 
bioactive glass composition consists of (in wt.%) 45% 𝑆𝑖𝑂2, 24.5% 𝑁𝑎2𝑂, 24.5% 𝐶𝑎𝑂, 6% 
𝑃2𝑂5, and is designated as 45S5 Bioglass® (35). This combination has been selected by the 
authors to provide a large amount of CaO with some 𝑃2𝑂5 in a 𝑁𝑎2𝑂 -𝑆𝑖𝑂2 matrix and is 
very close to a ternary eutectic, making it easy to melt (6). It entered clinical applications in 
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1985 and since then it has been widely used in dentistry, orthopaedics and maxillofacial 
surgery (36), especially cause of the chemical bond that it’s capable to form when in contact 
with the bone tissue (13). 
However, it is not considered to be the ideal biomaterial for inducing bone regeneration (37). 
One of the biggest problems attributed to the 45S5 Bioglass® relates to its high dissolution 
and degradation rates in vitro and in vivo (38) (39). An in vitro study using osteoblastic cells 
in the presence of glasses containing smaller amounts of sodium revealed that the sudden 
release of alkali ions caused a cytotoxic effect and decreased cell viability in comparison to 
an alkali-free composition (38). From this point of view, the 45S5 Bioglass® has a high 
dissolution rate (40). Consequently, this implicates a fast reabsorption which can negatively 
affect the natural bone remodelling and angiogenesis: the process of tissue repair is quicken, 
preventing its complete and uniform recovery, which can lead to the formation of a brittle 
bone. Specifically, the fast degradation rate of 45S5 Bioglass®, associated with its high 
alkaline content, does not suitably match the new bone growth rate leading to gap formation 
between the implant and bone tissue as concluded by Vogel et al. (41). Furthermore, Filho 
et al. (42) observed that the development of a crystalline phase, 𝑁𝑎2𝐶𝑎2𝑆𝑖3𝑂9, slightly 
reduced the rate of surface hydroxyapatite formation relative to amorphous bioactive glass 
45S5. The above issue was partly solved by Clupper and Hench (42), who carried out 
quantitative investigations on the effect of crystallinity on the apatite formation on bioglass 
surfaces in vitro. Their findings revealed that the crystal phase 𝑁𝑎2𝐶𝑎2𝑆𝑖3𝑂9 slightly 
decreased the formation kinetics of an apatite layer on the bioglass sample surface but it did 
not totally suppress the formation of such layer.  
All the above referred shortcomings derived from the high sodium also makes the processing 
in aqueous environment very difficult due to the leaching of 𝑁𝑎+ ions during degradation of 
the scaffold and the consequent variation of the pH value: this could inhibit osteoblasts 
activity and promote cells necrosis (7) (43). Moreover, scaffolds or powder compacts made 
of 45S5 Bioglass® can hardly be sintered due to the proximity between the onset of 
crystallization temperature (Tc) and the glass transformation temperature (Tg), as has been 
extensively documented in several literature reports.  Specifically, given the low Tc–Tg 
value, the printed scaffold is therefore likely fully crystalline prior to undergoing significant 
densification (T > 800 °C), and this behaviour leads bioglass to rapidly crystalize (44). As 
previously noticed, greater the crystalline phase and more will be the inert character of the 
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bioactive glass and the less will be the densification. This would imply a more fragile 
scaffold that will be composed of particles weakly bonded together.  Hence, a different and 
improved sintering protocol had to be implemented, to allow the production of a bioactive 
and biodegradable scaffold, with specific mechanical properties able to withstand the 
requirements for bone tissue regeneration. 
Other problems with alkali-containing glasses are related to the manufacturing: higher the 
alkali oxides content and lower will be the working range (temperature interval for glass 
formation) and more difficult will be the wet processing (to create a suspension for additive 
manufacturing). Specifically, the optimal sintering temperature is close to the crystallization 
one: this lead to the devitrification of the system, because of the high crystalline phase, which 
promotes high mechanical properties and could favour a more inert behaviour. Bioactivity 
however, as already discuss, depends also on the chemical composition of bioglass: changing 
on the alkali content of the scaffold allows a more versatility behaviour of the crystallization 
and sintering temperatures. Specifically, it’s also possible to assert that higher the content of 
silica, in the glass composition, higher would be the sintering window, and consequently 
reduced would be the crystallization tendency. On the other hand, higher the presence of Si, 
and higher will be the network connectivity: this directly affects the bioactivity and 
degradation rate of the glass, which tend to decrease (14).  
Attempting to overcome the above referred drawbacks, a series of alkali-free bioactive 
glasses compositions were recently proposed. They were designed in the glass forming 
region of Diopside (𝐷𝑖 − 𝐶𝑎𝑀𝑔𝑆𝑖2𝑂6)  Fluorapatite (𝐹𝐴 − 𝐶𝑎5(𝑃𝑂4)3𝐹)  Tricalcium 
phosphate (𝑇𝐶𝑃 − 3𝐶𝑎𝑂𝑃2𝑂5) ternary system (12), or in the binary (𝐷𝑖 − 𝐶𝑎𝑀𝑔𝑆𝑖2𝑂6)  
Tricalcium phosphate (𝑇𝐶𝑃 − 3𝐶𝑎𝑂𝑃2𝑂5) system (8). The production of Tricalcium 
phosphate based scaffold has already been done to realise artificial bones (45). However, 
their low toughness makes them not suitable for bone tissue regeneration: from this point of 
view, a Di-TCP system shows a higher ability to support heavy loading.  Moreover, this 
composition lead to the formation of a glass with high bioactivity (39) cause of the higher 
number of Q2 (Si) species (referring to the number of bridging oxygen atoms on the silica 
tetrahedron) and, thanks to the TCP, also with a good dissolution rate (8).  
In this regard, the composition Di-70-TCP-30 (Di-70) revealed to be very promising, 
justifying its selection in the frame of this work. Specifically, a recent research (16) pointed 
out how, by varying Di/TCP ratios, the obtained glass shows different properties: in 
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particular, it’s possible to obtain amorphous glasses only from compositions with Di ≥50 
wt.%, as the compositions with diopside contents varying between 30–50wt.% tend to 
spontaneous crystallization even after quenching in cold water. Moreover, glasses with Di 
≥60 wt.% exhibit good sintering temperature window wide enough for the fabrication of 
scaffolds. The Di-70 composition, in specific, presents a great differences between the 
crystallization temperature and the one of maximum shrinkage, showing that the kinetics of 
the two processes are independent one to the other (15).  
Therefore, in this project, the alkali-free bioactive glass (Di-70) will be used. The focus will 
be put on the production of scaffolds for medical purposes.  
 
4. Manufacturing method 
For the realization of a porous 3D structures with well-defined pore sizes and 
interconnectivities, in order to allow cell colonization and subsequent bone tissue 
regeneration, it’s strictly related to the production technique: it affects costs, reproducibility 
and the preservation of raw material’s properties.   
In order to be certain that all the requests of the scaffolds are satisfied, it is necessary to 
choose the right manufacturing method that obey to the following principles: 
• It must negatively the proprieties of the material shaped, neither both its chemical 
characteristics and bioactivity 
• It must allow to produce a scaffold that in the end present the correct porosity and 
structure designed in the 3D CAD model 
• It must be characterized by a solid reproducibility and easy scaffold designation 
Nowadays there are numerous processing techniques that allow the creation of a porous 
scaffold with adequate mechanical properties and ions and cells diffusion inside it.  The most 
conventional and used ones, as solvent casting, particulate leaching, phase separation, cannot 
be implemented in this project. The main reason behind this statement is that these 
techniques require the use of a specific and complex molds, don’t allow the precise control 
of the selected porosity and geometry, and, consequently the satisfaction of minimum 
mechanical proprieties. Moreover, these manufacturing methods cannot be easily used with 
bioactive glass or ceramics scaffolds in general. 
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4.1. Robocasting 
It’s necessary to investigate in other new technologies that allow the fabrication of materials 
with flexible processes. Best results have been obtained with Solid Freeform Fabrication 
(SFF) instead of conventional production methods: based on CAD models, it is possible to 
produce both simple and very complex scaffolds, in order to precisely recreate the part of 
bone to recover. Moreover, these techniques allow to control the porosity structure of the 
scaffold to facilitate cells and ions diffusion. In fact, a mandatory requirement for a scaffold, 
and particularly in bone engineering, is a controllable interconnected porosity to direct the 
cells to grow into the desired physical form and to support vascularization of the ingrown 
tissue. 
Robocasting is an extrusion-based, direct writing technique that utilizes high solids loaded 
paste-like suspensions (inks) to build 3D structures through a layer-wise deposition of 
extruded cylinders from a CAD program. Among other methods, this one can provide all the 
ideal characteristics required for a scaffold for medical application needs. 
However, additive manufacturing processes based on the deposition of a colloidal 
suspension that has been transformed into a pasty like system are very challenging in terms 
of rheological properties. They should not clog fine nozzles during the extrusion process and 
the extruded cylinders should be able to retain their shape right after deposition. These key 
requirements are hardly achievable when 45S5 Bioglass® is used. This explains why among 
a few thousands of papers about 45S5 Bioglass®, published up to 2013, there was not even 
one dealing with additive manufacturing. Only in this year a simple recipe was using 
carboxymethylcellulose (CMC) as single processing additive was for the first time used for 
the fabrication of porous 45S5 Bioglass® scaffolds by robocasting (7). From this point of 
view, challenging will be the creation of a suitable “ink”: robocasting requires a suspension 
with pseudo plastic behaviour and adequate stiffness (elastic modulus, G’), in order that it 
will shear thin and flow through the extruding orifice, but also maintain its shape. The 
realization of a dispersed high-solid-loading suspension of ceramic powder in a water 
medium is not yet functional to be implemented in this specific SFF technique, as it doesn’t 
possess any yield stress. This parameter covers an important role since determines the 
viscous behaviour of the paste, over its elasticity: the slurry will flow only if a certain 
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pressure is applied. This means that the rheology of the paste must be altered in order to 
create a partially flocculated suspension where a loosely bound particle network is formed. 
(46) From this perspective, as will be mentioned in the next Chapter, to obtain a paste with 
the above-mentioned characteristics is necessary to play whit particles surface properties of 
the material in the suspension.  
From the robocasting point of view, to achieve this goal, the suspension is created by the 
dispersion of the ceramic powder in water, with the addiction of an anionic dispersant 
compound. These, according to the traditional approach, should be adsorbed on the particles 
surface and stabilize the suspension. After this, suitable concentrations of salts or cationic 
species are added in order to create a flowable slurry: their role is to provoke a rheological 
change of the system in order to obtain a paste-like system with adequate elastic properties. 
The use of many components in this system leads to a difficult balance between the forces 
present into it: generally anionic and cationic substances tend to change the pH of the 
suspension and consequently the non-stabilization of the system (47).  
From this perspective, a simplified approach can be made by the using of a unique additive, 
the carboxymethylcellulose (CMC), which acts as multifunctional additive (binder, 
dispersant and gelation agent). Its low anionic behaviour facilitates adsorption and the 
versatility of rheological properties of the suspension, related to the MW added into it, and 
enables varying its flow properties. Specifically, CMC is a compound made of polymeric 
chains: they will interact with particles surface and partially being adsorbed into them. The 
remaining part of the polymer will adopt an extended configuration protruding from the 
surface, into the solution. The repulsion forces required for the creation of a partially 
flocculated suspension will arise from the compression mechanism between polymeric 
chains (48).  
The key of this project is not only the material (bioactive, biodegradable, specific rheology) 
but also its geometry: robocasting procedure enables to produce scaffolds with customized 
external structure (ability to adapt at the case of the patient) and internal pore architecture 
(to provide and facilitate bone tissue cells colonization).  
The combination of robocasting printing method, on one side, and alkali-free bioactive glass, 
on the other, considering all the advantages discussed in the previous pages, will provide a 
solid alternative for the manufacturing of scaffold for bone tissue regeneration. 
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4.1.1. Suspensions preparation and characterization 
As stated in the previous Chapter, the main purpose of this Thesis project is to evaluate the 
possibility of merging a material, an alkali-free bioactive glass, which showed promising 
properties in the field of tissue recovery, with a technique, the robocasting method, which 
exhibit favourable characteristics, in terms of geometry control. From this point of view the 
great issue encountered during the experimental work, was to create a glass dispersion 
suitable for the deposition and fabrication of a porous scaffold. 
 
4.1.1.1. Surface Proprieties 
A suspension can be generally defined as a dispersed phase of a two-component system in 
which the elements of the dispersed phase cannot be easily distinguished without the use of 
a microscope. Particles tend to interact with each other in different ways, depending on the 
particles surface characteristics and the additives used: these parameters promote the 
generation of forces which affect the aggregation degree of the system. 
Colloidal particles, by virtue of their small size, have a very large specific surface area and 
consequently affect and promote adsorption. Suspending particles in a liquid lead to charging 
of the surface, by either surface acids or bases (such as carboxylic, silane, or sulphate 
groups), by adsorption of free ions, as is typical in clays, or by adsorption of surfactants or 
polyelectrolytes. From this perspective, unless any precautions are taken, colloidal particles 
generally carry an electrical charge. The presence of charged particles surfaces, as result of 
Figure 3. Schematic representation of the double layer. (64) 
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the superficial ionization/hydration and/or of the specific adsorption of charged species, 
affects the ions distribution in its surroundings. In particular, the counter-ions distribution 
around the charged particle surface can be described with the double electric layer theory. 
In the surroundings of the charged particle a layer of counter-ions, called Stern layer, will 
form; here, ions are strictly attached to the surface and the electric potential decreases 
linearly with the increasing of the distance. Beside this layer, another one, called Gouy layer 
and made of ions and counter-ions diffusion will take place: the potential here decreases 
exponentially (13).  
The potential tends to be stable in the Stern region and, beyond it, decrease linearly under a 
constant, known as the Debye length, k1, which characterise the screaming effect produced 
by ions, as shown in the Equation 1:  
 𝑘−1 = √
𝜀𝑟𝜀0𝑘𝐵𝑇 𝑒2 ∑ 𝑐𝑖𝑧𝑖
2
2𝑁𝐴𝑒2𝐼
 (1) 
where 
I is the ionic strength of the electrolyte (mole/m3), 
ε0 is the permittivity of free space (farads per metre), 
εr is the dielectric constant (-), 
kB is the Boltzmann constant (1.3806×10
−23 J/K), 
T is the absolute temperature (K), 
NA is the Avogadro number (6.022×10
23 mol−1), 
e is the elementary charge (1.602×10−19 coulombs). 
 
The interaction potential influences the electrostatic forces between the particles. These 
forces depend interparticle’ distance: lower the gap among them higher will be the 
magnitude of the interaction forces. Consequently, the amount of work required to aggregate 
two charged particles depends on their electric potential: when this distance is high, the 
repulsion potential extends from the particle leading to a difficult aggregation and therefore 
to a stable suspension of dispersed particles. 
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This process of stabilization by electrostatic repulsion is described by the DLVO theory 
(named after Boris Derjaguin and Lev Landau, Evert Verwey and Theodoor Overbeek), 
which sums the forces of attraction of Van der Waals and of repulsion of the double electric 
layer, in a unique potential function, illustrated in Figure 4. As showed, the curve of total 
interaction presents a deep primary minimum and a secondary minimum, separated by an 
energy barrier, the maximum curve peak: this means that, to reach the aggregation point, 
particles must be close enough to enter in the primary minimum zone.  
The stabilization of the suspension does not depend only on the distance between particles, 
but it’s affected also by ions concentration and global charge, which influence the Debye 
length. On the other hand, the creation of a balanced suspension made out just from these 
parameters, can be only considered as kinetically stable: thermal fluctuations will eventually 
give enough energy to the particles to drive them over the primary minimum and allow 
aggregation. From this point of view, a more stable dispersed system can be achieved by 
ensuring a thermodynamic stability that can be imparted by steric repulsions from grafted or 
adsorbed active agents, known as dispersants. Those components stabilize ceramics 
suspensions by altering the natural condition and charge properties of the particle surface; 
their stabilization efficiency relays on the mechanism that create the repulsion forces 
between particles. Generally, most known dispersants are polymeric molecules, with 
ionizable groups in the chains, which can easily connect to the particles and allow physical 
Figure 4. Potential curve derived by the sum of repulsive and attractive potential, as described by the 
DLVO theory. (66) 
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repulsion: a part of the polymer will adsorb and stick to the surface, while the rest will stretch 
and permit particles separation. 
In other to realize a stable and dispersed suspension and simultaneously a paste able to be 
extruded, carboxymethylcellulose (CMC) was the selected as unique and multifunctional 
processing additive.  
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In this Chapter the experimental procedure will be presented, including the bioglass powder 
composition and preparation, as well as the main issues related to the manufacturing of a 
stable dispersion, able to be consequently printed with robocasting machine. 
Characterization of glass powder and suspension will be explained. 
 
1. Glass composition, preparation and characterization 
The bioactive glass composition of the binary system used in this Project, (𝐷𝑖 −
𝐶𝑎𝑀𝑔𝑆𝑖2𝑂6)  Tricalcium phosphate (𝑇𝐶𝑃 − 3𝐶𝑎𝑂𝑃2𝑂5) with the proportion of 70:30, is 
presented in Table 2. 
Table 2. Weight percentage composition of the Di70-TCP30 bioactive glass. 
%wt. 𝑺𝒊𝑶𝟐 𝑪𝒂𝑶 𝑴𝒈𝑶 𝑷𝟐𝑶𝟓 
Di70-TCP30 38.84 34.40 13.04 13.72 
 
As mentioned in section §4.1 of the previous Chapter, this glass composition aim to 
overcome the main disadvantages related to other oxides combinations, especially the ones 
containing alkali. From this point of view the binary system of Di-TCP could be considered 
as a promising solution: it’s been verified that Diopside based ceramics exhibit no general 
toxicity, help bone regeneration, as they contain elements which already compose bone 
tissue, and show great mechanical strength, even higher than hydroxypatite (8) (31) (49).  
Raw materials for the glass powder production are reagents that contain the oxides presented 
in the table above: SiO2, CaCO3, MgO and NH6PO4.  
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Homogeneous mixtures of glass reagents to obtain 80 g of glass were produced by ball 
milling for 10 minutes. Afterwards, the powder has been transferred to an alumina crucible 
for calcination at 850ºC for 2 hours (2ºC/min rate) and then the material was melted in 
platinum crucible with a three-step heating process: first 10ºC/min rate from 20ºC to 1200ºC, 
then 5ºC/min rate until 1570ºC, followed by a 2 hours’ dwell. The following quenching in 
cold water of the melted glass permitted to obtain glass frits, which were then dried in an 
oven at 100ºC for 24 hours. 
The robocasting machine requires the creation of a homogenous paste able to be extruded 
through the nozzle. It’s clear that the glass particle size and distribution play the principals 
roles. In order to avoid the clogging, to improve the packing of particles and to obtain a 
stable suspension, the glass went through different processes of particle size reduction. The 
frits were first milled in a planetary ball milling machine in dry conditions for 2 hours at a 
speed of 200 rpm (Retsch PM 400). The powder obtained was sieved (<40 µm) and its mean 
size was determined by a light scattering technique (Coulter LS230, Beckman Coulter; 
Fraunhofer optical model), being of about 4-5 µm.  
These fine glass particles were in part stored and in part submitted to an attrition milling in 
order to further decrease the particle size, the powder was milled in an attrition milling device 
for about 16 hours at a speed of 500 rpm, in ethanol; the solution of powder and ethanol was 
dried out again at 100ºC for 24 hours and then sieved (<40 µm) to eliminate agglomerates. 
The powder obtained had a mean size of about 1 µm. 
 
The amorphous nature of the glass frits was analysed by X-ray diffraction (XRD) analysis 
(Rigaku Geigerflex D/Max, Tokyo; Kapan; C Series, CuKα radiation; 2α angle range: 10º-
80º; step: 0.02º/s).  
The great advantage in the use of bioactive glass for scaffold production is their ability to 
strongly interact with the human body fluids and permit the formation of a hydroxyapatite 
layer on its surface: this will facilitate the subsequent bone tissue regeneration. The 
mechanism of this effect is not yet fully explained, even if different researches were done 
(50) (51) and showed that basically consists in 12 stages of reactions which occur in the 
material-tissue interface. Every step of the HA layer mechanism formation has a different 
speed; in a general way, it’s possible to state that the rapidity of these stages is related to the 
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bioactivity of the material: since this property defines the response after the contact with 
living tissue, higher the bioactivity and faster will be the creation of the HA layer. 
From this point of view, it’s necessary to underline how the choice of the material with right 
surface properties and behaviour, in particular with the adequate biological response, is very 
important. One of the novelties in this Thesis is the implementation of an alkali-free 
bioactive glass; as stated in the previous Chapter, this choice is related to the numerous 
disadvantages associated with the presence of alkaline (mainly Na+ ions) in a biodegradable 
scaffold. From the phase point of view, it has been shown how this type of element, inside 
the glass, influences the sintering process (44): the low difference between the crystallization 
and glass transition temperature imply a greater crystallization over the densification 
mechanism of the bioglass and therefore, the alkali content in the glass lead to a higher 
presence of crystal structure. Since this phase affects the bioactivity and tends to decrease 
the rate of the HA layer formation as already mentioned, it is clear that the main point on the 
bioglass production is to obtain an almost fully amorphous structure.  
After, Differential Thermal Analysis (DTA) and Thermogravimetric (TGA) were supposed 
to be on the glass in the equipment present in the Laboratories: Seteram Labsys DTA/TG-
DSC, with a heating rate of 10ºC/min, from 25ºC to 1000ºC. The aim of these analyses was 
to identify the nature of the reactions that could occur during the heating process and the 
relevant temperatures at which the principal transformations take place. Due to limited time, 
this kind of analysis were not done. 
 
1.1. CMC Solution Preparation 
As previous stated, carboxymethylcellulose is a compound made of polymeric chains and 
can be found with different molecular weight. The type used in this Project was the CMC 
250 (Mw=250,000) in the powder state but many difficulties were encountered in the 
realization of a homogeneous mixing of CMC and water, due to its strong tendency to 
agglomerate (14). In order to facilitate and speed up the creation of the final paste, a stock 
solution was prepared containing the amounts required for preparing suspensions with 50% 
vol.% solids and containing added CMC amounts of 2 wt.% and 3 wt.%.  
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1.2. Suspension Preparation 
The suspensions analysed were subjected to a process of deagglomeration in a planetary 
centrifugal mixer machine (THINKY, Japan) during subsequent steps of work, in order to 
obtain a homogeneous and smooth paste. For this reason, it was decided to prepare the 
suspension in the following manner: 
(i) the amounts of CMC and water (if requested) are added in the container and mixed 
for 4 minutes at 1200 rpm 
(ii) cycles of 4min at 700 rpm and of 4 min at 1200 rpm were used in 4 steps, while half 
of the powder of each (45 and 1 µm, in sequence) was added at every round 
(iii) a final cycle of 2 min at 1200 rpm was made in order to obtain a more uniform 
suspension 
In order to cool down and allow the rehydration of the paste, it was maintained in fridge 
temperatures (4-14°C) for 15 minutes and then prepared for the scaffold printing process. 
 
 
Figure 5. THINKY planetary centrifugal mixer machine used 
 
1.3. Characterization 
The main issue related to the creation of a suspension was to get a homogeneous paste-like 
system, able to be implemented in the robocasting machine. Many attempts were made in 
order to create an “ink” with a unique particle size, but results obtained were not satisfying 
enough, nor easily reproducible. For these reasons and in the interest of improving the 
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packing between particles, a 50:50 wt.% mixture of two bioactive glass powders with mean 
sizes of ~1 µm and 45 µm was used.  
After this selection, the study proceeded by preparing suspensions with increasing total 
amounts of solids and of CMC aiming at finding the most appropriate dispersion conditions 
for processing Di70-TCP30, namely maximizing the solids loading while keeping a suitable 
flow behaviour for the extrusion of the pastes through the fine nozzles. Table 4 summarises 
the different suspensions tested. 
The effects of the different solid and additive combinations in the gelification behaviour of 
the suspensions were analysed through rheological measurement methods in oscillatory way 
(Kinexus, Malvern, United Kingdom) at room temperature, with cutting tension between 0.1 
and 1000 Pa in order to determine the linear viscoelastic region (LVE), at an oscillatory 
frequency of 1Hz, with a plate/plate testing combination.  
Viscosity tests were also made in order to verify the shear tinning behaviour of the created 
suspensions, by analysing them by varying the shear rate from 0 to 400s-1 at room 
temperature. 
 
Table 3. Illustration of the different combination of Vol. % of solids and wt. % of CMC studied. 
Vol. % water Vol. % solid Wt. % CMC 
60 40 2 
60 40 3 
57 43 2 
57 43 3 
56 44 3 
55 45 2 
55 45 3 
52 48 2 
50 50 2 
.  
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2. Scaffold production and characterization 
The alkali-free bioactive glass scaffolds were produced by using a robotic deposition 
machine, the 3D Ink, LLC, which allows, by the use of the Robocad software, the creation 
of different structures, with desired porosity size. In this Project, three variants were printed: 
300µm, 400µm and 500µm.  
 
Figure 6. Robocasting machine, 3D Ink LLC 
 
 
 
 
For the realization of the scaffold structure were used the parameters showed in the following 
Table 4 and illustrated in the Figure 5. 
Figure 7. CAD model of the scaffold printed with three different porosities: 300µm (a), 400µm (b), 500µm 
(c) 
Experimental Procedure 
 
31 
 
 
 
The suspension, previously produced, was inserted in a 5mL syringe and placed in the 
robocasting machine; in order to avoid a differential drying of the different layers, the paste 
was printed on a plate flood in an oil bath. After the deposition, the scaffolds were extracted 
and let to dry at room temperature for 48 hours.   
 
Figure 8. 5mL syringe with attached pin of 410µm 
 
Following, scaffolds were subject to a phase of sintering made of different temperature step 
and heating rate: first, with 5°Cmin-1 until 200°C, then until 600°C at a heating rate of 
0.4°Cmin-1, and a final step at 2°Cmin-1 until 800°C. 
Design Parameter µm 
Porosity Size (a) 300 400 500 
Filament Width (b) 410 410 410 
Distance between filaments (c) 710 810 910 
Table 4. Design parameters for the scaffold production. 
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Once the scaffolds went through sintering, they were characterized in terms of 
microstructure, pore size, porosity. The evaluation of mechanical strength under 
compression will be performed in a near future after the defence in order to complete 
gathering all the required data for writing and publishing a scientific article. 
 
2.1. Microstructure 
The microstructure was observed with Scanning Electron Microscope (SEM) technology, 
by analysing the transversal section of the printed scaffolds, after they were subjected to the 
adequate sample preparation: they were fixed with double sided carbon glue in aluminium 
sample holder and covered with a carbon film obtained in a carbon evaporator machine 
(EMITECH K950). 
 
2.2. Pore Size 
The pore size after sintering was checked through the SEM images, by using a digital 
elaborator program for images, the ImageJ software. The total shrink was calculated with 
the following equation: 
 𝑆% =
𝑤𝑖 − 𝑤𝑓
𝑤𝑓
∙ 100 (2) 
 
Figure 9 . Illustration of the design parameters on the 3D scaffold 
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Where wi and wf, correspond respectively to the initial (after deposition, settled in the 
robocasting machine) and final (after sintering) pore size. 
 
2.3. Porosity 
Subsequently, density tests were made in order to determine the porosity of the final obtained 
scaffolds, physical parameter directly related to the strength of the sample itself. Starting 
from the values of mass and volume of the sintered bodies, the apparent density was 
determined; since the theoretical density of the bioactive glass used is known from literature 
to be 2,92gcm-3, it’s possible to calculate the porosity percentage of the scaffolds with the 
following equation: 
 𝑃(%) = (1 −
𝜌𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡
𝜌𝑡ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙
) ∙ 100 (3) 
 
For the calculation of the apparent density, mass and volume is requested. In order to do this, 
the sintered scaffolds were firstly cut in 9 cubes, same which will after undergoing the 
mechanical tests. The value of the sample mass was obtained by using a laboratory analytic 
balance, while the volume was arithmetically established after the evaluation of the three 
dimensions (a, b, c) of the sample with a digital calliper. Both for the mass and for the volume 
determination, three measures were taken and then just the average value will be used in the 
numerical calculation.  
Table 5. Average values of the sample dimensions and weight. 
 a [mm] b [mm] c [mm] V [mm3] m [gr] 
300µm 2.7 2.7 3.2 22.5 0.0313 
400µm 2.9 2.9 3.1 25.5 0.0324 
500µm 3.3 3.2 3.1 32.7 0.0384 
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2.4. Mechanical Strength 
The samples, in form of cubes, were subject to compression tests in order to evaluate the 
Young’s Modulus and the mechanical strength. To accomplish this, a general mechanical 
tester machine, SHIMADZU AG-IS, with speed of load application of 0.5mm.min-1 and a 
load cell of 5kN, was implemented.  
The value of the tension, is given by the ratio of the force applied per area unity (defined by 
the a and b parameter), given respectively from the machine acquired force data and the 
calculated transversal section subjected to the applied load. It’s valid the following equation: 
 𝜎(𝑀𝑃𝑎) =
𝐹
𝐴
 (4) 
 
The material deformation can be expressed as the ratio between the height variation, before 
and after the compression test, and the initial height of the sample: 
 𝜀 =
∆ℎ
ℎ0
 (5) 
 
Consequently, the Young’s Modulus can be calculated with the following equation: 
 𝐸 =
𝜎
𝜀
 (6) 
 
It’s necessary to underline that, due to the time spent on the analysis of the rheological 
properties of the different combinations of the suspensions, it was not possible to determine 
the mechanical strength of the produced scaffolds. 
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Results and Discussion 
 
 
In this Chapter data obtained from the described tests will be presented, including also 
powder particles size distribution. The behaviour and character of the suspension analysed 
will be illustrate with the viscosity and oscillation tests. The decisions made in the 
Experimental approach will be explained as well as the discussion of the obtained values. 
 
1. Glass Characterization 
1.1. Crystallographic Analysis 
The spectra obtained from the X-rays done on the bioactive glass frits, illustrated in Figure 7, shows 
the absence of crystal phase, confirm, in this way, the amorphous structure of the glass quenched in 
water. In order to obtain a biocompatible scaffold it’s necessary that the amorphous phase of the 
material is mantained after the sintering process. For this reason an XRD analysis was made over the 
sintered scaffold and shown in Figure 8, the amorphous structure is mantained.  
Figure 10. XRD of the Di70-TCP30 bioactive glass, with amorphous structure. 
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1.2. Size Reduction and Granulometric Analysis 
In order to prepare a suspension able to be implemented in the robocasting machine, it’s 
necessary to reduce the frits size to a micrometer scale. Therefore, the glass frits went 
through subsequent comminution stages until obtaining the desired small particle sizes. 
The most challenging issue encountered in this Project was the realization of a stable and 
with adequate rheological characteristics paste. In this sense, it’s possible to generally define 
two main requirements to produce a correct suspension: 
(i) The system inserted in the syringe and then extruded through the nozzle must 
present a shear thinning behaviour in order to not clog the pin and be easily 
deposit by the robocasting machine 
(ii) Since the main final purpose of this work is to realize a scaffold for bone tissue 
regeneration, the printed body must present a minimum strength in order to act 
as an adequate replacement of the tissue functions, until their complete 
restoration. 
In term of paste production these demands strongly depend on the particle size and 
distribution. In fact, as well investigated (15) (16), these properties totally affect the 
rheological properties. In particular, it’s possible to assert that bigger the particle size, easier 
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Figure 11. XRD of the Di70-TCP30 bioactive glass after sintering, with amorphous 
structure. 
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will be the realization of the paste but higher will be also the risk to obtain a system with a 
shear thickening behaviour and lower will be the maximum solid loading. On the other hand, 
finer the particle size and more difficult will be the work required to obtain a homogeneous 
dispersion of the material in suspension, since, cause of their high surface energy, they tend 
to strongly interact and attach to each other, already discussed in Chapter 2. From this 
perspective, using a combination of two different average particle sizes, allows a better 
packing of the system, and therefore, enables increasing the solid loading in order to get a 
better mechanical behaviour of the final printed scaffold (17) (18).  
The milling process is fundamental, as stated previously, in order to have control on the 
particle size and distribution, and consequently regulate the rheological behaviour of the 
paste. Therefore, two powder frits, one with a mean particle size of 1 µm, and the other with 
a mean particle size of 4-5 µm were mixed in a 1:1 weight ratio to prepare the suspensions. 
In Figure 8 is showed the particle size distribution obtained after submitting the glass frits 
for 1 hour and 2 hours at 200rpm in the planetary milling machine, in order to investigate 
the effect of dry milling time on particle size reduction. 
 
This powder was then collected and milled again in the attrition milling machine. Figure 9 
shows the evolution of the particle size distribution after different stages of time, until the 
mean size of about 1µm.  
Figure 12. Particle size distribution after different time of the bioactive glass in the planetary 
milling machine. 
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2. Paste Characterization 
The mechanism of surface interaction between different particles has been described in the 
§2 of the previous Chapter. It became clear that one of the main issue encountered in the 
experimental part of this Project was the creation of a paste with specific rheological 
behaviour, able to flow through the nozzle of the robocasting machine and to retain the shape 
designed in the CAD model, after deposition. On the other hand, after optimizing the particle 
size distribution, in order to gain a more packing system, the next step was aimed at 
increasing as much as possible the solid loading: higher this value and greater will be the 
mechanical response of the final scaffold. From this perspective, it was necessary to analyse 
the effect of different bioactive glass solid loadings on its rheological properties.  
It is worthy underlining that the suspensions are composed of two parts, the solid, composed 
by the glass powder and the CMC (which amount will be calculated as a weight fraction of 
the glass part), and the liquid, composed by distillated water. As well described in previous 
chapters, the CMC is the unique additive chose for this Project, as it can act both as 
dispersant and binder, depending on the amount added. From this point of view, starting 
from previous researches and studies related to the printing of bioactive glasses with CMC 
(7) (19), it was decided to firstly investigate the rheological properties of the paste with a 
fixed amount of CMC (2%), while varying the solid loading. 
Figure 13. Particle size distribution after different time of the bioactive glass in the attrition milling 
machine. 
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As mentioned, a paste is able to be implemented in the robocasting technique if it shows a 
shear thinning behaviour and, in order to obtain a final scaffold with adequate mechanical 
properties, the suspension must also present a suitable value of Elastic Modulus (G’). To 
verify the viscosity and visco-elastic behaviour, the paste was subjected to two different 
tests, respectively in viscometry and oscillatory mode of the rheometer. 
In Figure 10, the results of the viscosity analysis are reported.  
 
 
Figure 14. Viscosity profile of suspension with increasing amount of solid loading and fixed quantity of 
CMC. 
 
It can be seen that all the tested suspension exhibit shear thinning behaviour: in fact, there’s 
the tendency, in all the reported curves, to a decrease in the viscosity when they are driven 
to flow at high rates. As expected, with increasing solid loading, the viscosity profile tends 
to shift upper; the increased volume occupied by the glass particles lead to a less viscous and 
more elastic system. 
Thanks, moreover, to the great packing of the paste, due to the dual particle size used for its 
production, it was possible to analyse a wide variation of the solid loading, starting from 
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40%vol until reaching the 50%vol. It must be underlined however the irregular and 
anomalous behaviour of the 50%vol solid suspension: the viscosity tends to decrease with 
increasing shear rate but exhibit, at 100s-1, a drop and variation of the past attitude, since the 
viscosity move to higher values. This strange behaviour it’s possibly related to the high solid 
loading of this suspension and a trend for shear induced agglomeration. The resulting 
suspension becomes difficult to flow homogeneously under the applied shear stress and the 
observed drops are likely due to slippery effects of the measuring sensor that momentary 
loses adherence and contact with the suspension. When the contact between the measuring 
sensor and the testing suspension in a momentary re-established gives rise to the observed 
irregular increases in the viscosity. The anomalous flow behaviour of the system with 50 
vol.% solids might also be due to some lack of initial homogenisation. Therefore, more 
stages of powder addition and mixing into the planetary machine have been used thereafter 
in the preparation of the suspensions. From this point of view is clear how the dispersal of 
the particles more and more difficult as the solid volume fraction of the paste increase. 
In order to determine the overall nature of the suspensions and to investigate how the solid 
loading affects the mechanical properties, oscillatory tests were carried out and the results 
are shown in the Figure 11. 
 
Figure 15. Visco-elastic behaviour of suspension with increasing amount of solid loading and fixed 
quantity of CMC, analysed in the oscillatory mode. 
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When a material is used in the robocasting machine, it’s subjected to deformation during the 
extrusion process that partially destroy the system network, so it must flow under the applied 
pressure, but it must recover its structure and shape once deposited. The capacity of a paste 
to present this kind of behaviour is determined by the LVE region in the Elastic Modulus 
test. In fact, this can be approximated as the “working zone” of the material: it is represented 
by the shear stress range in which the value of elastic modulus is stable and consequently 
determines the condition region in which it’s possible to assess the internal structure and 
judge about the stiffness of the paste and the shape retention capacity of the extruded 
filaments. The wideness of the LVE range determines if the material is able to withstand the 
robocasting applied pressure and also able to retain its shape after extrusion.  
As the reported curves show, all the suspension combinations present a large work zone 
which is then suitable for robocasting: final inks stay stable along all the shear stress range 
tested, suggesting that the deposited filaments will be mechanically stable and capable of 
fully supporting their own weight during the assembly. The graph shows, however, a strange 
and non-expected evolution of G’ with increasing solid loadings. As a matter of fact, the 
variations in elastic modulus when passing from 40 vol.% to 45 vol.% and 48 vol.% are 
relatively small. A further increase in solid loadings to 50 vol.% led to a significant jump in 
G’, which would enhance the mechanical stability of the scaffolds. However, once this paste 
was loaded into the syringe it was not capable to be extruded due to its high stiffness.  
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Figure 16. Effect of the increased amount of CMC with fixed solids loading. 
 
 
Figure 17. Viscosity profile of suspension with increasing amount of solid loading and variable quantity of 
CMC 
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With the purpose to both reach the maximum possible solid loading and to obtain an 
extrudable paste, it was decided to analyse what was the effect of the variation of CMC 
amount and the solids volume fractions. Figure 12 and Figure 13 display the apparent 
viscosity curves of suspensions with solids loading within the range of 40-45 vol.% and 
containing 3 wt.% CMC and compares them with those of suspensions containing 2 wt.% 
CMC and 48-50 vol.% solids. It is possible to observe that the overall shear thinning 
behaviour was conserved in all systems. But again, the same slippery effect observed in 
Figure 10 have apparently occurred for the most concentrated suspension. It must be 
underlined also that the flow curves became smoother when the added amount of CMC was 
increased to 3 wt.%. these results suggest that particles start colliding more often whit each 
other under flow conditions when the solid loading is increased due to their closer proximity, 
gradually hindering the flow. Increasing the amount of CMC in the dispersion liquid 
enhances its intrinsic viscosity, limiting the total achievable concentration of solids, while 
tending to hinder particle segregation. Therefore, optimizing the flow behaviour is a trade of 
suitably combining the right amounts of solids and processing additive for a given particle 
size distribution. On the other side, the use of a plate/plate system in the rheometer influence 
the profiles and tend to be less trustable than a cone/plate combination in the measurement 
of the viscosity.  
As reported in Figure 14, all the tested combination of solid loading with 3%CMC as 
additive show an elastic response that fill the gap between the 48%vol and 50%vol with 
2%CMC:  
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Figure 18. Visco-elastic behaviour of suspension with increasing amount of solid loading and variable 
quantity of CMC, analysed in the oscillatory mode. 
 
These curves reveal that it is possible to reach high G’ values even with the lowest solid 
loading (40%) provided that the amount of CMC is increased to 3 wt.%. this confirms that 
playing with solid loading and the added amount of processing additive enables formulating 
suitable pastes for additive manufacturing by robocasting. The pastes contain 3 wt.%CMC 
exhibit intermediate G’ values among the extreme cases of pastes with added 2 wt.%CMC. 
From this point of view, the graph (Figure 14) shows as promising solutions the suspensions 
with 43 vol.%, 44 vol.% and 45 vol.% solids. However, when attempting to print using the 
systems with 44 vol.% and 45 vol.% solids, handling of the pastes upon filling the syringes 
was difficult and extrusion of these pastes was not possible. For these reasons, it was decided 
to work, print and analyse just one combination: the 43 vol.% solid loading with 3 wt.% 
CMC. 
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3. Scaffold Characterization 
3.1. Morphologic Analysis 
The shape stability of the extruded filaments can be inferred from the SEM images of 
scaffolds after deposition (green sample) are shown in Figure 15. 
 
It can be seen the filament size is approximately the same as that of the extrusion nozzle 
dimension (410µm). the measured small differences can be attributed to shrinkage upon 
drying and eventual small deformation of the filaments upon extrusion. The pore size tends 
to be reduced in respect to the one imposed in the CAD program. This is expected as the 
overall dimensions of scaffolds are reduced upon drying. However, all SEM micrographs 
reveal structures with well-defined and interconnected pores, an important feature to allow 
a good vascularization. The deposited filaments were mechanically stable and capable of 
fully supporting their own weight during the assembly, as deduced from the absence of 
significant shape deformation caused by overlapping the other layers, as shown in Figure 15, 
with the side section of the scaffolds.  
 
 
 
Figure 19. Magnification of printed scaffold before sintering with different porosity; (a) 300µm, (b) 
400µm, (c) 500µm. 
Figure 20. Side section of printed scaffolds before sintering with different porosity; (a) 300µm, (b) 400µm, 
(c) 500µm. 
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The same measurements were made for the scaffolds after sintering; results are reported in 
Figure 17 and Figure 18.  
 
 
 
 
The SEM micrographs also provide evidences about the good adhesion between adjacent 
layers: features which are essential for obtaining 3D sintered structures with strong 
mechanical properties. The filaments section is generally dense, but it’s possible to see also 
some isolated pore, due to a not precise removal of all the air bubbles presented inside the 
syringe during the paste loading. 
 
3.2. Pore Size 
Thanks to the SEM pictures obtained, it was possible to calculate the pore size of the scaffold 
before and after sintering and consequently determine its shrinkage during the heating 
process. Table 6 shows the values. As expected, due to the relative low amount of solid 
loading into the paste, after the sintering process the scaffold tend to be subjected to a 
shrinkage effect.  
Figure 22. Magnification of printed scaffold after sintering with different porosity after sintering; (a) 
300µm, (b) 400µm, (c) 500µm. 
Figure 21. Side section of printed scaffolds after sintering with different porosity; (a) 300µm, (b) 400µm, 
(c) 500µm. 
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Table 6. Pore sizes calculated from the SEM images and relative shrinkage in case of different porosity 
Theoretical size Before After Shrinkage 
300 252±6 173±2 45.6% 
400 351±10 282±8 24.5% 
500 439±6 345±3 27.5% 
 
3.3. Porosity 
The porosity fractions of the scaffolds were calculated as it has been described in Chapter 3. 
A scaffold, intended to be used as a temporary substitute of the bone tissue engineering and 
regeneration must present an adequate porosity fraction: not too high to compromise the 
mechanical response, and not too low to prevent ions and cells diffusion and their optimal 
growth. The obtained values are presented in Table 7. 
Table 7. Pore size and porosity values calculated. 
Pore size Porosity 
300µm 52.3% 
400µm 56.5% 
500µm 59.9% 
 
As expected the porosity tend to increase with the increasing of the space between rods but 
the values of the three-different scaffold are very similar to each other. However, due to the 
same reasons mentioned above for pore size and total shrinkage, the estimated values are 
affected by the same deformation events and the real porosity needs to be better evaluated 
using geometrical approaches and or on immersion measurements using the Archimedes 
principle. 
 
3.4. Mechanical Strength 
The analysis of the mechanical properties of the sintered scaffolds is necessary in order to 
estimate its capacity to be used as a bone substitute. From this point of view, they must 
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possess a minimum compression strength enough adequate to sustain the loads that will have 
to support and a modulus of elasticity close to the native tissue, so that the distribution of 
loads is identical.  
 
Figure 23. Tensions values of the samples with different pore size and porosity trend. 
 
Table 8. Tension values of the samples, referred to the different pore sizes. 
Pore size [µm] Compressive Strenght [MPa] 
300 9.94 ± 1.71 
400 8.03 ± 2.51 
500 3.90 ± 0.42 
 
 
As reported in Figure 19 and Table 8, the values of tension calculated have the expected 
trend: with the increasing of the pore size, and consequently the porosity (see Table 7), the 
tension tends to decrease.  
Since the compressive strength of the spongy part of the bone structure varies between 2-12 
MPa (20), it’s possible to observe that all the tested scaffolds present strength values 
included in the range reported above and they could therefore be used as substitutes.  
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 Conclusions 
 
The aim of this Master Thesis was the realization of 3D porous scaffolds made of alkali-free 
bioactive glass with the robocasting technique, in order the fabricate devices suitable for 
bone tissue regeneration. The study was then divided in different steps: 
(i) Glass preparation through melt quenching technique and subsequent size 
reduction to state of micrometric powder. As proved and discussed, the particle 
size distribution represents a critical parameter in the creation of a dispersed 
suspension with controlled rheological behaviour. For this reason, a double 
sized glass powder was fabricated 
(ii) Preparation of concentrated glass based suspensions and relative 
characterization. Starting from the requirements requested from the robocasting 
technique for the character and behaviour of the paste, many attempts were made 
in terms of glass and additive combinations, in order to obtain a satisfactory 
suspension 
(iii) Fabrication of bioactive glass scaffolds with different porosity size with the 
robocasting additive manufacturing technique, with subsequent characterization 
It became clear along this work that promising results could be obtained many by playing 
with the particle size distribution that controls the particle packing ability along the 
fabrication process. A 1:1 glass mixture of glass powders having mean particle diameters of 
1 m and 45 m enabled preparing suitable suspensions by playing with the contents of 
CMC and solid loading. From the Viscosity and Elastic Modulus measurements it could be 
concluded that for a fixed overall particle size distribution, the other most determining 
experimental factors are the solids loading and the added amount of CMC. An added amount 
of 2 wt.% of CMC enables higher solid loading to be achieved, but the flow behaviour at the 
maximum solids loading revealed to be inadequate for the extrusion process, due to the high 
stiffness of the paste, shear induced aggregation and consequent slippage effects. On the 
other hand, decreasing solids loading in the presence of 2 wt.% of CMC caused accentuated 
decreases in the elastic modulus. In contrast, increasing the amount of CMC to 3 wt.% 
enables more gradual and controlled changes in the viscoelastic properties of the pastes while 
imposed lower limits for the maximum solid loading.  
 54 
 
Robocasting technique revealed a good additive manufacturing technique permitting to exert 
a high control over the scaffold structure and internal porosity. The realized scaffolds present 
good characteristics. The shape of the extruded rods was reasonably preserved, and of the 
overall porous structure was maintained stable and uniform. 
As mentioned, most of the work focused over the study of the glass particle size distribution, 
the suspension rheology and viscoelastic behaviour, suitable for the robocasting extrusion 
technique and for the realisation of scaffolds with adequate mechanical response. The time 
left after these tasks was therefore little to complete all the characterization analysis of the 
printed scaffolds, especially in terms of its bioactivity and biological response. On the other 
hand, most of this Thesis work focused on the rheological properties. From this perspective 
it was possible to obtain a glass suspension with both great elastic modulus G’ and valid 
viscosity profile: these were the main components to satisfy in order to have a paste able to 
be printed through the robocasting machine. 
  
Future Work 
In order to define better the interaction forces generated between CMC and glass particles, 
a deeper analysis on the effective steric effect of the additive could help in the control of the 
rheological properties of the suspensions.  
Other aspects that need to be better equated are related to the description of the structure of 
the scaffolds through more realistic measurements of porosity and shrinkage.  
Although this selected bioactive glass composition has already demonstrated to exhibit 
excellent in vitro properties, it has never been tested with a scaffold structure. Therefore, it 
would also be interesting to investigate in vitro the effects of pore size on the differentiation 
and proliferation processes of hMSC. Similarly, in vivo studies would be worthy to be 
performed to test the suitability of the scaffolds for the intended applications. 
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